Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Daniela Doerfel, MD, Michael Gutknecht, Melanie Märklin, Lothar Kanz, MD, Helmut R. Salih, MD, Frank Gruenebach, Martin R Müller, MD PhD, Susanne M Rittig, MD

Blood (2014) 124 (21): 1416.

https://doi.org/10.1182/blood.V124.21.1416.1416

Published: 2014

Journal Articles

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Michael Gutknecht, Simone Joas, Lothar Kanz, MD, Helmut R Salih, MD, Susanne M Rittig, MD, Frank Gruenebach, PhD

Blood (2012) 120 (21): 1050.

https://doi.org/10.1182/blood.V120.21.1050.1050

Published: 2012

Journal Articles

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Mark-Alexander Schwarzbich, MD, Michael Gutknecht, Lisa Guettler, Lothar Kanz, MD, Helmut R. Salih, MD, Frank Gruenebach, PhD, Susanne Malaika Rittig, MD

Blood (2011) 118 (21): 3232.

https://doi.org/10.1182/blood.V118.21.3232.3232

Published: 2011

Journal Articles

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

Tina Baessler, Jean E Charton, Corina Buechele, Benjamin J Schmiedel, Frank Gruenebach, Matthias Krusch, MD, Alexander Wacker, Lothar Kanz, MD, Helmut R Salih, MD

Blood (2009) 114 (22): 279.

https://doi.org/10.1182/blood.V114.22.279.279

Published: 2009

Journal Articles

BCR/ABL Inhibitors Influence Phenotype and Function of Monocyte-Derived Human Dendritic Cells.

Susanne M. Schmidt, Christian J. Lechner, Frank Gruenebach, Julia Salih, Lothar Kanz, Hans-Georg Rammensee, Helmut R. Salih

Blood (2009) 114 (22): 1116.

https://doi.org/10.1182/blood.V114.22.1116.1116

Published: 2009

NARROW

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

BCR/ABL Inhibitors Influence Phenotype and Function of Monocyte-Derived Human Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

BCR-ABL Tyrosine Kinase Inhibitors Interfere with the PI3K/Akt Signalling Pathway and Activate the Microphthalmia-Associated Transcription Factor (MITF) in Human Dendritic Cells

Inhibition of PI3K/Akt and Erk Signaling Pathways by BCR-ABL Tyrosine Kinase Inhibitors up-Regulates the Immunosuppressive Receptor Osteoactivin in Monocyte-Derived Dendritic Cells

Immunosuppressive Drugs Upregulate the Immunoinhibitory Receptor Osteoactivin in Monocyte-Derived Dendritic Cells,

Consequences of 4-1BB-4-1BB Ligand Interaction for NK Cell Anti-Tumor Immunity: Opposite Effects of Seemingly Analogue Molecules in Mice and Men.

BCR/ABL Inhibitors Influence Phenotype and Function of Monocyte-Derived Human Dendritic Cells.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only